Maria Sklodowska-Curie National Research Institute of Oncology

Warsaw, Masovian Voivodeship 02-781

0 studies enrolling now · 2 studies all time

What they study most

Metastatic Melanoma, Non-Small-Cell Lung Cancer, Unresectable Melanoma

Studies at this site

• CAB-AXL-ADC Safety and Efficacy Study in Adults With NSCLC — Completed
• IO102-IO103 in Combination With Pembrolizumab Versus Pembrolizumab Alone in Advanced Melanoma (IOB-013 / KN-D18) — Running, not enrolling